{"id":"W4408272010","doi":"10.21203/rs.3.rs-5984691/v1","title":"Interleukin-12 anchored drug conjugate (tolododekin alfa) in patients with advanced solid tumors: Results of a first-in-human Phase 1 trial","year":2025,"lang":"en","type":"preprint","venue":"Research Square","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Solid tumor; Conjugate; Medicine; Drug; Antibody-drug conjugate; Oncology; Phase (matter); Pharmacology; Internal medicine; Cancer; Immunology; Physics; Mathematics; Antibody; Monoclonal antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001072208,0.0009099745,0.001145663,0.0002048172,0.0002109319,0.0009319027,0.0003452703,0.0008932869,0.003229273],"category_scores_gemma":[0.0008380581,0.0002540171,0.00111905,0.0002231275,0.0005326437,0.0007292393,0.0002756931,0.002069232,0.000705654],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006404278,"about_ca_system_score_gemma":0.0008433938,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006241669,"about_ca_topic_score_gemma":0.001166892,"domain_scores_codex":[0.999721,0.0001386246,0.000009182176,0.00004121509,0.00002180776,0.0000681948],"domain_scores_gemma":[0.9995701,0.0001294831,0.00007195033,0.00003457486,0.00002289831,0.0001710166],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7400422,0.01836575,0.003000929,0.0005876194,0.001426676,0.0002048955,0.0001633879,0.0041481,0.02331603,0.0005362079,0.007990092,0.2002181],"study_design_scores_gemma":[0.7887595,0.1914007,0.007451501,0.00006633133,0.0006011843,0.0002052977,0.00006384779,0.001537911,0.00423081,0.0005203645,0.005132075,0.00003046308],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9868371,0.005895191,0.0008304775,0.00157062,0.0002598417,0.0006493138,0.001564834,0.0001177039,0.002274911],"genre_scores_gemma":[0.9842178,0.00438617,0.001833971,0.001175888,0.0001895067,0.0006948449,0.002779499,0.00005913215,0.004663344],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003229273,"threshold_uncertainty_score":0.01080292,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03341631292622424,"score_gpt":0.4399543575598095,"score_spread":0.4065380446335852,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}